TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 27,500,000 Value ($000) $17,725 Avg Close — Range —
Q1 2024
Shares 25,500,000 Value ($000) $16,389 Avg Close — Range —
Q4 2023
Shares 22,500,000 Value ($000) $14,965 Avg Close — Range —
Q3 2023
Shares 25,000,000 Value ($000) $16,145 Avg Close — Range —
Q2 2023
Shares 25,000,000 Value ($000) $20,401 Avg Close — Range —
Q1 2023
Shares 20,000,000 Value ($000) $19,701 Avg Close — Range —